221608-res-1-at_NEW

Figure S1: Time-To-Dispense: Days from positive SARS- CoV-2 test to nirmatrelvir/ritonovir dispensing 40.0 35.0 30.0 25.0 20.0 15.0 10.0 5.0 0.0 0 1 2 3 4 5 Day from test for SARS-CoV-2 Treated Untreated (imputed)                       Appendix 1, as supplied by the authors. [...]     Percent     Appendix 1, as supplied by the authors. [...]         Appendix 1, as supplied by the authors. [...]         Appendix 1, as supplied by the authors. [...]       Figure S3: Forest plot of weighted odds ratios with 95%CIs, and NNT, for all‐cause death only at 30 days in patients exposed to  nirmatrelvir/ritonavir compared to those unexposed. OST=Ontario Science Table; DDI=drug‐drug‐interaction; LTC=long‐term care      Appendix 1, as supplied by the authors.